NEAL KLEIMAN to Genetic Therapy
This is a "connection" page, showing publications NEAL KLEIMAN has written about Genetic Therapy.
Connection Strength
0.078
-
Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease. Am J Cardiol. 2003 Nov 07; 92(9B):24N-31N.
Score: 0.034
-
A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol. 2003 Oct 15; 42(8):1339-47.
Score: 0.034
-
Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. Am Heart J. 2007 May; 153(5):874-80.
Score: 0.011